Culture

UIC researchers invent new gene-editing tool

Researchers from the University of Illinois Chicago have discovered a new gene-editing technique that allows for the programming of sequential cuts -- or edits -- over time.

CRISPR is a gene-editing tool that allows scientists to change the DNA sequences in cells and sometimes add a desired sequence or genes. CRISPR uses an enzyme called Cas9 that acts like scissors to make a cut precisely at a desired location in the DNA. Once a cut is made, the ways in which cells repair the DNA break can be influenced to result in different changes or edits to the DNA sequence.

The discovery of the gene-editing capabilities of the CRISPR system was described in the early 2010s. In only a few years, scientists became enamored with the ease of guiding CRISPR to target almost any DNA sequence in a cell or to target many different sites in a cell in a single experiment.

"A drawback of currently available CRISPR-based editing systems is that all the edits or cuts are made all at once. There is no way to guide them so that they take place in a sequential fashion, one after the other," said UIC's Bradley Merrill, associate professor of biochemistry and molecular genetics at the College of Medicine and lead author of the paper.

Merrill and colleagues' new process involves the use of special molecules called guide RNA that ferry the Cas9 enzyme within the cell and determine the precise DNA sequence at which Cas9 will cut. They call their specially engineered guide RNA molecules "proGuides," and the molecules allow for the programmed sequential editing of DNA using Cas9.

Their findings are published in the journal Molecular Cell.

While proGuide is still in the prototype phase, Merrill and colleagues plan to further develop their concept and hope that researchers will be able to use the technique soon.

"The ability to preprogram the sequential activation of Cas9 at multiple sites introduces a new tool for biological research and genetic engineering," Merrill said. "The time factor is a critical component of human development and also disease progression, but current methods to genetically investigate these processes don't work effectively with the time element. Our system allows for gene editing in a pre-programmed fashion, enabling researchers to better investigate time-sensitive processes like how cancer develops from a few gene mutations and how the order in which those mutations occur may affect the disease."

Credit: 
University of Illinois Chicago

Reclusive neutron star may have been found in famous supernova

video: This computer model from a paper by Orlando and collaborators shows the remnant in 2017, incorporating data taken by Chandra, ESA's XMM-Newton and Japan's Advanced Satellite for Cosmology and Astrophysics (ASCA).

Image: 
INAF-Osservatorio Astronomico di Palermo/Salvatore Orlando

Since astronomers captured the bright explosion of a star on February 24, 1987, researchers have been searching for the squashed stellar core that should have been left behind. A group of astronomers using data from NASA space missions and ground-based telescopes may have finally found it.

As the first supernova visible with the naked eye in about 400 years, Supernova 1987A (or SN 1987A for short) sparked great excitement among scientists and soon became one of the most studied objects in the sky. The supernova is located in the Large Magellanic Cloud, a small companion galaxy to our own Milky Way, only about 170,000 light-years from Earth.

While astronomers watched debris explode outward from the site of the detonation, they also looked for what should have remained of the star's core: a neutron star.

Data from NASA's Chandra X-ray Observatory and previously unpublished data from NASA's Nuclear Spectroscopic Telescope Array (NuSTAR), in combination with data from the ground-based Atacama Large Millimeter Array (ALMA) reported last year, now present an intriguing collection of evidence for the presence of the neutron star at the center of SN 1987A.

"For 34 years, astronomers have been sifting through the stellar debris of SN 1987A to find the neutron star we expect to be there," said the leader of the study, Emanuele Greco, of the University of Palermo in Italy. "There have been lots of hints that have turned out to be dead ends, but we think our latest results could be different."

When a star explodes, it collapses onto itself before the outer layers are blasted into space. The compression of the core turns it into an extraordinarily dense object, with the mass of the Sun squeezed into an object only about 10 miles across. These objects have been dubbed neutron stars, because they are made nearly exclusively of densely packed neutrons. They are laboratories of extreme physics that cannot be duplicated here on Earth.

Rapidly rotating and highly magnetized neutron stars,called pulsars, produce a lighthouse-like beam of radiation that astronomers detect as pulses when its rotation sweeps the beam across the sky. There is a subset of pulsars that produce winds from their surfaces - sometimes at nearly the speed of light - that create intricate structures of charged particles and magnetic fields known as "pulsar wind nebulae."

With Chandra and NuSTAR, the team found relatively low-energy X-rays from SN 1987A's debris crashing into surrounding material. The team also found evidence of high-energy particles using NuSTAR's ability to detect more energetic X-rays.

There are two likely explanations for this energetic X-ray emission: either a pulsar wind nebula, or particles being accelerated to high energies by the blast wave of the explosion. The latter effect doesn't require the presence of a pulsar and occurs over much larger distances from the center of the explosion.

On a couple of fronts, the latest X-ray study supports the case for the pulsar wind nebula -- meaning the neutron star must be there -- by arguing against the scenario of blast wave acceleration. First, the brightness of the higher energy X-rays remained about the same between 2012 and 2014, while the radio emission detected with the Australia Telescope Compact Array increased. This goes against expectations for the blast wave scenario. Next, authors estimate it would take almost 400 years to accelerate the electrons up to the highest energies seen in the NuSTAR data, which is over 10 times older than the age of the remnant.

"Astronomers have wondered if not enough time has passed for a pulsar to form, or even if SN 1987A created a black hole," said co-author Marco Miceli, also from the University of Palermo. "This has been an ongoing mystery for a few decades and we are very excited to bring new information to the table with this result."

The Chandra and NuSTAR data also support a 2020 result from ALMA that provided possible evidence for the structure of a pulsar wind nebula in the millimeter wavelength band. While this "blob" has other potential explanations, its identification as a pulsar wind nebula could be substantiated with the new X-ray data. This is more evidence supporting the idea that there is a neutron star left behind.

If this is indeed a pulsar at the center of SN 1987A, it would be the youngest one ever found.

"Being able to watch a pulsar essentially since its birth would be unprecedented," said co-author Salvatore Orlando of the Palermo Astronomical Observatory, a National Institute for Astrophysics (INAF) research facility in Italy. "It might be a once-in-a-lifetime opportunity to study the development of a baby pulsar."

The center of SN 1987A is surrounded by gas and dust. The authors used state-of-the-art simulations to understand how this material would absorb X-rays at different energies, enabling more accurate interpretation of the X-ray spectrum, that is, the amount of X-rays at different energies. This enables them to estimate what the spectrum of the central regions of SN 1987A is without the obscuring material.

As is often the case, more data are needed to strengthen the case for the pulsar wind nebula. An increase in radio waves accompanied by an increase in relatively high-energy X-rays in future observations would argue against this idea. On the other hand, if astronomers observe a decrease in the high-energy X-rays, then the presence of a pulsar wind nebula will be corroborated.

The stellar debris surrounding the pulsar plays an important role by heavily absorbing its lower energy X-ray emission, making it undetectable at the present time. The model predicts that this material will disperse over the next few years, which will reduce its absorbing power. Thus, the pulsar emission is expected to emerge in about 10 years, revealing the existence of the neutron star.

Credit: 
Center for Astrophysics | Harvard & Smithsonian

Models to predict dengue, zika and yellow fever outbreaks are developed by researchers

image: Monkey being examined in Manaus area. Scientists will monitor areas in which these diseases are endemic to investigate the factors that trigger outbreaks

Image: 
CREATE-NEO

By Maria Fernanda Ziegler | Agência FAPESP – Yellow fever was the first human disease to have a licensed vaccine and has long been considered important to an understanding of how epidemics happen and should be combated. It was introduced to the Americas in the seventeenth century, and high death rates have resulted from successive outbreaks since then. Epidemics of yellow fever were associated with the slave trade, the US gold rush and settlement of the Old West, the Haitian Revolution, and construction of the Panama Canal, to cite only a few examples.

Centuries after the disease was first reported in the Americas, an international team of researchers will embark on a groundbreaking study to develop models that predict epidemics of yellow fever and other diseases caused by mosquito-borne arboviruses such as dengue, zika, and chikungunya.

“Knowledge of these diseases, their cycles ,and the possibilities of new outbreaks is very well-established, but we still lack a systematic understanding of how to predict when outbreaks will occur. Our goal is to create predictive models to help monitor and combat outbreaks, protect the public, and develop a deeper understanding of the combination of factors that leads to epidemics,” said Maurício Lacerda Nogueira, a professor at the São José do Rio Preto Medical School (FAMERP) in the state of São Paulo, Brazil, and a member of the CREATE-NEO project funded by the US National Institutes of Health (NIH).

The new study is part of a Thematic Project supported by FAPESP to monitor the mosquito population in the urban area of São José do Rio Preto and the monkey and mosquito populations in the transition zone between rural and urban Manaus, the Amazonas state capital.

In addition to FAMERP, the Brazilian research centers that are participating in the initiative include the National Institute for Research on the Amazon (INPA), the Federal University of Mato Grosso (UFMT), the Federal University of Amazonas (UF AM), and the Heitor Vieira Dourado Foundation for Tropical Medicine (FMT-HVD). Participants located elsewhere include the University of Texas Medical Branch (UTMB), New Mexico State University (NMSU), the Massachusetts Institute of Technology (MIT), and Cary Institute of Ecosystem Studies in the US, and the Gorgas Memorial Institute for Health Studies (ICGES) in Panama, among others.

An article written by the researchers to mark the project’s inception is published in Emerging Topics in Life Science, reviewing the factors that influence the potential re-emergence of yellow fever in the Neotropics.

“Deforestation, seasonal variations in rainfall and non-human primate populations are all factors that influence outbreaks, but we need to know the tipping-point for each one, and to find that out we’ll develop predictive models based on research and monitoring conducted in arbovirus hotspots in São Paulo, Amazonas and the Pantanal in Brazil, and in Panama,” Nogueira said.

The history of yellow fever shows that outbreaks occur at intervals of between seven and ten years. “Brazil has many arboviruses, with outbreaks and even epidemics in progress all the time,” said Livia Sacchetto, also a researcher at FAMERP and a member of CREATE-NEO.

From forest to city and vice-versa

According to Sacchetto, the project also aims to find out more about spillovers and, if possible, anticipate these outbreaks in which arboviruses jump from humans to animals or vice-versa. Dengue, zika, and chikungunya are transmitted to humans and non-human primates by infected Aedes aegypti mosquitoes. In the case of yellow fever, A. aegypti is the urban vector but mosquitoes of a different genus (Haemagogus) are responsible for transmission in the countryside (sylvatic cycle).

Despite the existence of a highly effective vaccine since 1937, and no reported cases caused by urban transmission since 1942, sylvatic outbreaks of yellow fever frequently spill over into cities. “Many people and monkeys die of yellow fever in Brazil and other parts of the Americas, as well as in Africa,” Sacchetto said. “Despite the vaccine and progress in controlling transmission of the disease, we continue to see cases emerging from the sylvatic cycle. The virus is endemic in part of Brazil, with persistent circulation between mosquitoes and non-human primates, which are its primary hosts.”

This enzootic cycle is far from easy to control. “Once established, the enzootic cycle ensures that the virus stays in forests or other rural areas, but it can spread to a city via accidental infection of a human,” she said. Circulation of the virus in cities raises concerns about a return of the urban cycle involving transmission by A. aegypti. “Hence the importance of epidemiological surveillance studies and maintenance of large-scale vaccine coverage to control outbreaks.”

Predictive models for arboviruses also take into account climate change and urbanization destroying native vegetation. “We have active cases of yellow fever in both non-human primates and humans in the Southern states of Paraná and Santa Catarina. This hasn’t happened for several decades,” Nogueira said.

In Africa, from which yellow fever came to the Americas, most cases of the disease occur in the sub-Saharan region. Urban yellow fever is a major public health concern, with frequent outbreaks that are hard to predict.

In the Americas, as the authors of the review article note, yellow fever has historically been reported from northern Panama to northeastern Argentina. In recent years, most cases have occurred in the Amazon Basin during the rainy season, when population densities of Haemagogus mosquitoes are at their highest, but the number of reported cases following sylvatic spillover has increased in Peru, Bolivia, and Paraguay, as well as Brazil.

The article “Re-emergence of yellow fever in the Neotropics - quo vadis?” (doi: 10.1042/ETLS20200187) by Livia Sacchetto, Betania P. Drumond, Barbara A. Han, Mauricio L. Nogueira and Nikos Vasilakis can be read at: portlandpress.com/emergtoplifesci/article/4/4/411/227095/Re-emergence-of-yellow-fever-in-the-neotropics-quo.

Journal

Emerging Topics in Life Sciences

DOI

10.1042/ETLS20200187

Credit: 
Fundação de Amparo à Pesquisa do Estado de São Paulo

Managing suicide risk in research study participants

What should researchers do if they encounter a study participant who reports suicidal thoughts?

UIC College of Nursing associate professor Susan Dunn explores this question as lead author of "Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness," a paper published in the January/February edition of Nursing Research.

Suicide is ranked as the 10th leading cause of death for all ages in the U.S. and can be identified through clinical research, according to the paper.

Although suicide screening tools are widely available for patients in emergency, hospital and primary care settings and have been used in research, there is a "significant gap" in the availability of published suicide risk management protocols for use in research studies, the authors wrote.

Because of this, Dunn, who is conducting an NIH-funded study on hopelessness in cardiac patients, says she developed a protocol "from the ground up" to identify, measure and act on suicidal ideation expressed by study participants.

The safety of participants is essential in research, and staff administering studies must be prepared to evaluate and act on suicidal signals from patients, the paper's authors wrote.

"For those research studies when we know patients are at higher risk --and definitely hopelessness does put a patient at higher risk for suicide -- a suicide risk management protocol should absolutely be in place," Dunn says in an interview. "It gives me, as the [principal investigator], peace of mind to know the data collectors -- the nurses doing the intervention -- are all trained to be able to recognize if there is a potential for suicidal ideation."

Dunn's protocol uses the Columbia-Suicide Severity Rating Scale to score whether a patient is at low, moderate or high risk for suicide. Those scores then trigger next steps. For high or moderate risk levels, that would mean stopping data collection, immediately contacting both a mental health resource and the patient's provider, and making sure the patient is supervised. For low risk, it means providing a list of mental health resources. The protocol also requires that those staffing the study take a free online training to use the Columbia scale, participate in role-playing training to be able to identify and act on various suicidal risk levels, and participate in booster trainings (annually or when the protocol changes).

"The reason I wanted to publish the protocol is so that others can use it as a model for their own research," she says.

Age-adjusted suicide rates increased 30% from 2000 to 2016, according to the paper, and Dunn says they're even higher now due to the COVID-19 pandemic.

"Especially when you think about the current situation we find ourselves in with the pandemic, we know that suicide rates are higher," Dunn says. "How many studies are assessing for suicidal ideation? I think that's a significant issue. It's not always being assessed in high-risk patients."

Credit: 
University of Illinois Chicago

Positive reinforcements help algorithm forecast underground natural reserves

Texas A&M University researchers have designed a reinforcement-based algorithm that automates the process of predicting the properties of the underground environment, facilitating the accurate forecasting of oil and gas reserves.

Within the Earth's crust, layers of rock hold bountiful reservoirs of groundwater, oil and natural gas. Now, using machine learning, researchers at Texas A&M University have developed an algorithm that automates the process of determining key features of the Earth's subterranean environment. They said this research might help with accurate forecasting of our natural reserves.

Specifically, the researchers' algorithm is designed on the principle of reinforcement or reward learning. Here, the computer algorithm converges on the correct description of the underground environment based on rewards it accrues for making correct predictions of the pressure and flow expected from boreholes.

"Subsurface systems that are typically a mile below our feet are completely opaque. At that depth we cannot see anything and have to use instruments to measure quantities, like pressure and rates of flow," said Siddharth Misra, associate professor in the Harold Vance Department of Petroleum Engineering and the Department of Geology and Geophysics. "Although my current study is a first step, my goal is to have a completely automated way of using that information to accurately characterize the properties of the subsurface."

The algorithm is described in the December issue of the journal Applied Energy.

Simulating the geology of the underground environment can greatly facilitate forecasting of oil and gas reserves, predicting groundwater systems and anticipating seismic hazards. Depending on the intended application, boreholes serve as exit sites for oil, gas and water or entry sites for excess atmospheric carbon dioxide that need to be trapped underground.

Along the length of the boreholes, drilling operators can ascertain the pressures and flow rates of liquids or gas by placing sensors. Conventionally, these sensor measurements are plugged into elaborate mathematical formulations, or reservoir models, that predict the properties of the subsurface such as the porosity and permeability of rocks.

But reservoir models are mathematically cumbersome, require extensive human intervention, and at times, even give a flawed picture of the underground geology. Misra said there has been an ongoing effort to construct algorithms that are free from human involvement yet accurate.

For their study, Misra and his team chose a type of machine-learning algorithm based on the concept of reinforcement learning. Simply put, the software learns to make a series of decisions based on feedback from its computational environment.

"Imagine a bird in a cage. The bird will interact with the boundaries of the cage where it can sit or swing or where there is food and water. It keeps getting feedback from its environment, which helps it decide which places in the cage it would rather be at a given time," Misra said. "Algorithms based on reinforcement learning are based on a similar idea. They too interact with an environment, but it's a computational environment, to reach a decision or a solution to a given problem."

So, these algorithms are rewarded for favorable predictions and are penalized for unfavorable ones. Over time, reinforcement-based algorithms arrive at the correct solution by maximizing their accrued reward.

Another technical advantage of reinforcement-based algorithms is that they do not make any presuppositions about the pattern of data. For example, Misra's algorithm does not assume that the pressure measured at a certain time and depth is related to what the pressure was at the same depth in the past. This property makes his algorithm less biased, thereby reducing the chances of error at predicting the subterranean environment.

When initiated, Misra's algorithm begins by randomly guessing a value for porosity and permeability of the rocks constituting the subsurface. Based on these values, the algorithm calculates a flow rate and pressure that it expects from a borehole. If these values do not match the actual values obtained from field measurements, also known as historical data, the algorithm is penalized. Consequently, it is forced to correct its next guess for the porosity and permeability. However, if its guesses were somewhat correct, the algorithm is rewarded and makes further guesses along that direction.

The researchers found that within 10 iterations of reinforcement learning the algorithm was able to correctly and very quickly predict the properties of simple subsurface scenarios.

Misra noted that although the subsurface simulated in their study was simplistic, their work is still a proof of concept that reinforcement algorithms can be used successfully in automated reservoir-property predictions, also referred as automated history matching.

"A subsurface system can have 10 or 20 boreholes spread over a two- to five-mile radius. If we understand the subsurface clearly, we can plan and predict a lot of things in advance, for example, we would be able to anticipate subsurface environments if we go a bit deeper or the flow rate of gas at that depth," Misra said. "In this study, we have turned history matching into a sequential decision-making problem, which has the potential to reduce engineers' efforts, mitigate human bias and remove the need of large sets of labeled training data."

He said future work will focus on simulating more complex reservoirs and improving the computational efficiency of the algorithm.

Credit: 
Texas A&M University

Oxidation processes in combustion engines and in the atmosphere take the same routes

image: Laboratory set-up of the free-jet experiment at TROPOS in Leipzig, which allows the investigation of the early phase of oxidation reactions under atmospheric conditions without the walls influencing the reaction behaviour.

Image: 
Torsten Berndt, TROPOS

Thuwal/Helsinki/Leipzig. Alkanes, an important component of fuels for combustion engines and an important class of urban trace gases, react via another reaction pathways than previously thought. These hydrocarbons, formerly called paraffins, thus produce large amounts of highly oxygenated compounds that can contribute to organic aerosol and thus to air pollution in cities. An international research team has now been able to prove this through laboratory experiments with state-of-the-art measurement technology at the University of Helsinki and the Leibniz Institute for Tropospheric Research (TROPOS) in Leipzig.

The results of this interdisciplinary work provide crucial information about oxidation processes both in combustion engines and in the atmosphere - with direct implications for engine efficiency and the formation of aerosols, especially in cities, the research team writes in the journal Communications Chemistry, an open-access journal published by the Springer-Nature publishing group.

Oxidation processes play a major role both in the atmosphere and in combustion. A chain reaction called autoxidation is enabled by high engine temperatures. But it also acts as an important source of highly oxygenated compounds in the atmosphere that form organic aerosol, as researchers from Finland, Germany and the USA demonstrated in 2014. Autoxidation is one reason for ageing processes of organic compounds by oxygen from the air. It contributes to the spoilage of food and wine.

This chain reaction is initiated by the formation of peroxy radicals (RO2). The propensity of organic compounds to undergo such multistep autoxidation determines the ignition timing of fuels in engines and, on the other hand, the potential for the formation of low-volatility condensable vapours and consequently organic aerosol in the atmosphere. The extent to which multistep autoxidation takes place depends on the molecular structure of the organic compounds and the reaction conditions. Determining the different reaction pathways of peroxy radicals, which are important intermediates in all oxidation reactions, is crucial for the formation of the different reaction products and their key properties, which can ultimately affect both human health and the climate.

Since peroxy radicals are very reactive, their chemical reactions take place very quickly and individual reaction steps were thus overlooked for a long time. The discovery of highly oxygenated organic molecules (HOMs) seven years ago was only possible due to advances in measurement techniques. A special mass spectrometer (Chemical Ionisation - Atmospheric Pressure Interface - Time of Flight (CI-APi-TOF) mass spectrometer), that can monitor the very short-lived compounds, was used now to measure the radicals and oxidation products of alkanes. "Until now, there have been no studies on HOM formation from alkanes because it was assumed that their structure would be unfavourable for autoxidation," reports Dr. Torsten Berndt from TROPOS. Methane, an important greenhouse gas, belongs to the group of alkanes. But the most important fossil fuels of the world economy from crude oil and natural gas also consist of alkanes: these include propane, butane, pentane, hexane, heptane and octane. New findings about the oxidation behaviour of this group of substances therefore have great relevance in many areas.

To gain a deeper insight into alkane autoxidation, experiments were carried out in the free-jet flow reactor at TROPOS in Leipzig in addition to experiments in Helsinki. The experimental set-up is optimised so that the gases do not come into contact with the walls during the reaction in order to exclude interferences of the results by wall processes. During the experiments, almost all reactive intermediates, RO2 radicals and their reaction products could be directly monitored. The interdisciplinary cooperation of researchers from combustion chemistry and atmospheric chemistry proved to be very useful, because in the combustion processes analogous processes take place as in the atmosphere, only at a higher temperature. "As a result, it became visible that not only isomerisation reactions of RO2 radicals but also of RO radicals are responsible for the build-up of higher oxidised products. The study made it possible to identify with the alkanes the last and perhaps most surprising group of organic compounds for which autoxidation is important", Torsten Berndt concludes.

Even at high concentrations of nitrogen oxides, which otherwise quickly terminate autoxidation reactions, the alkanes apparently produce considerable amounts of highly oxidised compounds in the air. The new findings allow for a deeper understanding of autoxidation processes and give rise to further investigations on isomerisation reactions of RO radicals.

Credit: 
Leibniz Institute for Tropospheric Research (TROPOS)

Machine learning aids in simulating dynamics of interacting atoms

image: Automated data set generation provides a highly diverse sampling of atomic positions for training an accurate and general machine learning model.

Image: 
Los Alamos National Laboratory

LOS ALAMOS, N.M., February 23, 2021--A revolutionary machine-learning (ML) approach to simulate the motions of atoms in materials such as aluminum is described in this week's Nature Communications journal. This automated approach to "interatomic potential development" could transform the field of computational materials discovery.

"This approach promises to be an important building block for the study of materials damage and aging from first principles," said project lead Justin Smith of Los Alamos National Laboratory. "Simulating the dynamics of interacting atoms is a cornerstone of understanding and developing new materials. Machine learning methods are providing computational scientists new tools to accurately and efficiently conduct these atomistic simulations. Machine learning models like this are designed to emulate the results of highly accurate quantum simulations, at a small fraction of the computational cost."

To maximize the general accuracy of these machine learning models, he said, it is essential to design a highly diverse dataset from which to train the model. A challenge is that it is not obvious, a priori, what training data will be most needed by the ML model. The team's recent work presents an automated "active learning" methodology for iteratively building a training dataset.

At each iteration, the method uses the current-best machine learning model to perform atomistic simulations; when new physical situations are encountered that are beyond the ML model's knowledge, new reference data is collected via expensive quantum simulations, and the ML model is retrained. Through this process, the active learning procedure collects data regarding many different types of atomic configurations, including a variety of crystal structures, and a variety of defect patterns appearing within crystals.

Credit: 
DOE/Los Alamos National Laboratory

Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment

image: These 3D images of neurons in the brain of a schizophrenia patient show wavy, distorted neurites, which indicate that the condition may be linked to the shape of the neurons. X-ray images were taken at the Advanced Photon Source.

Image: 
Ryuta Mizutani

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior. Symptoms include delusions, hallucinations, difficulty processing thoughts and an overall lack of motivation. Schizophrenia patients have a higher suicide rate and more health problems than the general population, and a lower life expectancy.

There is no cure for schizophrenia, but the key to treating it more effectively is to better understand how it arises. And that, according to Ryuta Mizutani, professor of applied biochemistry at Tokai University in Japan, means studying the structure of brain tissue. Specifically, it means comparing the brain tissues of schizophrenia patients with those of people in good mental health, to see the differences as clearly as possible.

“There are only a few places in the world where you can do this research. Without 3D analysis of brain tissues this work would not be possible.” — Ryuta Mizutani, professor, Tokai University

“The current treatment for schizophrenia is based on many hypotheses we don’t know how to confirm,” Mizutani said. “The first step is to analyze the brain and see how it is constituted differently.”

To do that, Mizutani and his colleagues from several international institutions collected eight small samples of brain tissue — four from healthy brains and four from those of schizophrenia patients, all collected post-mortem — and brought them to beamline 32-ID of the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory.

At the APS, the team used powerful X-rays and high-resolution optics to capture three-dimensional images of those tissues. (Researchers collected similar images at the Super Photon Ring 8-GeV [SPring-8] light source facility in Japan.) The resolution of the X-ray optics used at the APS can be as high as 10 nanometers. That’s about 700 times smaller than the width of the average red blood cell, and there are five million of those cells in a drop of blood.

“There are only a few places in the world where you can do this research,” Mizutani said. “Without 3D analysis of brain tissues this work would not be possible.”

According to Vincent De Andrade, physicist in Argonne’s X-ray Science Division, capturing images at high resolution presents a challenge, since the neurons being imaged can be centimeters long. The neuron is the basic working unit of the brain, a cell within the nervous system that transmits information to other cells to control body functions. The human brain has roughly 100 billion of these neurons, in various sizes and shapes.

“The sample has to move through the X-ray beam to trace the neurons through the sample,” De Andrade explained. “The field of view of our X-ray microscope is about 50 microns, about the width of a human hair, and you need to follow these neurons over several millimeters.”

What these images showed is that the structures of these neurons are uniquely different in each schizophrenia patient, which Mizutani said is evidence that the disease is associated with those structures. Images of healthy neurons were relatively similar, while neurons from schizophrenia patients showed far more deviation, both from the healthy brains and from each other.

More study is needed, Mizutani said, to figure out exactly how the structures of neurons are related to the onset of the disease and to devise a treatment that can alleviate the effects of schizophrenia. As X-ray technology continues to improve — the APS, for example, is scheduled to undergo a massive upgrade that will increase its brightness up to 500 times — so will the possibilities for neuroscientists.

“The APS upgrade will allow for better sensitivity and resolution for imaging, making the process of mapping neurons in the brain faster and more precise,” De Andrade said. “We would need resolutions of better than 10 nanometers to capture synaptic connections, which is the holy grail for a comprehensive mapping of neurons, and those should be achievable with the upgrade.”

De Andrade also noted that while electron microscopy has been used to map the brains of small animals — fruit flies, for instance — that technique would take a long time to image the brain of a larger animal, such as a mouse, let alone a full human brain. Ultrabright, high energy X-rays like those at the APS, he said, could speed up the process, and advances in technology will help scientists get a more complete picture of brain tissue.

For neuroscientists like Mizutani, the end goal is fewer people suffering with brain diseases like schizophrenia.

“The differences in brain structure between healthy and schizophrenic people must be linked to mental disorders,” he said. “We must find some way to make people healthy.”

Credit: 
DOE/Argonne National Laboratory

New vaccine needed for serious childhood pneumonia

A UNSW Sydney-led medical research team has called for a new vaccine, improved strategies and enhanced monitoring to combat serious complications from childhood pneumonia.

The researchers examined the impact of the 13-valent pneumococcal conjugate vaccine (13vPCV) on childhood pneumonia and empyema - complicated pneumonia - after its introduction to the Australian National Immunisation Program about a decade ago.

The new study, published in Thorax recently, found that while 13vPCV resulted in a 21 per cent decrease in childhood pneumonia hospitalisations, there was a contemporaneous 25 per cent increase in admissions for empyema.

This incidence data for childhood empyema hospitalisations is similar to that reported in other countries.

Approximately 7000 Australians under the age of 18 are hospitalised with pneumonia each year.

Senior author Professor Adam Jaffe, Head of the School of Women's and Children's Health at UNSW Medicine & Health, said the researchers' findings suggested an emergence of non-vaccine serotypes - those which 13vPCV does not cover.

13vPCV was introduced to cover the 13 most common serotypes responsible for invasive pneumococcal infection, extending coverage to six additional serotypes including 1 and 3.

The previous vaccine (7vPCV) covered seven serotypes. A serotype is a distinct variation within a bacteria species.

Prof. Jaffe said: "Although we found a substantial reduction in serotype 1, serotype 3 is now the predominant organism which causes childhood empyema - in 76 per cent of cases - so, efforts must be made to create a vaccine which is more effective against serotype 3.

"In fact, Australia recently changed the vaccination dosage schedule to try and improve the effectiveness of 13vPCV against serotype 3, but we need to continue monitoring patients using molecular techniques to see if this change has had an impact.

"Childhood bacterial pneumonia and empyema are potentially preventable diseases through vaccination. So, if Australia can develop an effective vaccine, we could prevent children from being hospitalised with pneumonia and empyema."

Empyema is infected fluid around the lungs and about one per cent of children hospitalised with pneumonia develop it.

Although children are highly unlikely to die from empyema, they can expect a long stay in hospital for treatment with antibiotics and surgery, or the insertion of a drain. If adults develop empyema, about a third are likely to die.

Continuing enhanced surveillance needed

The researchers conducted a similar study during the period of the superseded 7vPCV. Their new study - which took four years to complete - is part of a broader research project on 13vPCV.

"Our new study had two parts," Prof. Jaffe said. "We analysed national hospitalisations for childhood empyema and childhood pneumonia, then we conducted an enhanced surveillance study on children with empyema."

The first part of the research used publicly available hospitalisations data - about 36,000 admissions - to assess whether the introduction of 13vPCV changed how many children were admitted to hospital with pneumonia and empyema.

The enhanced surveillance study involved the collection of blood and lung fluid samples from 401 children with empyema from February 2015 to September 2018.

The children were receiving treatment in 11 major children's hospitals across Australia.

Most children were boys (208 or 52 per cent) and the median age was four years old.
The researchers then conducted molecular testing on these samples and compared the results to their previous study undertaken during the period of 7vPCV.

The multidisciplinary team included Dr Nusrat Homaira, of the Discipline of Paediatrics at UNSW Medicine & Health, and paediatric research nurse Roxanne Strachan of Sydney Children's Hospital.

Prof. Jaffe said: "Our new research is the first of its kind in Australia - so, we now have the best data available for complicated childhood pneumonia to help guide future vaccination introductions and improve vaccine strategies.

"We are currently working on our larger study, of which this was a subset, to examine the effectiveness of 13vPCV on children with bacterial pneumonia. We will need to repeat the study in a few years' time to help with monitoring.

"In the meantime, it would make a big difference if molecular testing of patients' lung fluid was routine in laboratories, because that would ensure we had the best real-time data available which will help rationalise antibiotic choice; also, we would have no need to seek funding to undertake this much-needed research."

Credit: 
University of New South Wales

Follow the smell of the ocean to find where marine predators feed

image: The chemical DMSP is released when phytoplankton are consumed by zooplankton such as krill.
DMSP is decomposed into DMS and released into the water and air.
The concentration of DMS is higher in dense zooplankton areas. There appears to be no correlation between fish biomass and DMS.
When marine predators, such as whales, move toward higher concentrations of DMS, they can reach higher densities of food (zooplankton).

Image: 
Professor Kei Toda

A joint research project between organizations in Japan and the US has demonstrated that zooplankton, a major food source for marine predators, can be located by following the concentration gradient of the chemical dimethyl sulfide (DMS) in ocean water and air. Currently, little is known about how marine predators search for and find enough food to maintain their body size. This study is expected to expand research into the chemical triggers of marine organisms while foraging.

Zooplankton, such as krill and copepods are the main energy source for many large marine animals. The big predators must consume a large amount of these tiny creatures to provide enough energy to power their enormous bodies. How they find their food is still not clearly understood.

Krill feed on phytoplankton which produce and retain water-soluble compounds in their bodies to cope with osmotic pressure. This is essential for survival in seawater. One of these compounds is dimethylsulfoniopropionate (DMSP). DMSP contains sulfur elements and is zwitterionic, meaning that it has both a positive and a negative charge like an amino acid. It is broken down by bacteria into DMS, a component of the familiar aromas associated with ocean air or dried seaweed. DMSP stored in phytoplankton is released into seawater when zooplankton graze on the phytoplankton, which is hypothesized to result in higher DMS concentrations in dense zooplankton areas. It is thought that marine predators could use DMS concentration to locate food sources. While attraction to artificially released DMS has been shown in some predatory species, whether natural gradients of DMS are used by predators and serve as a useful foraging cue remains unknown.

To investigate the phenomenon, an international team of researchers from Kumamoto University and Woods Hole Oceanographic Institution developed a new instrument to continuously and automatically analyze seawater and atmospheric concentrations of DMS. Together with a researcher from Stony Brook University, they then used the device to conduct a survey in June 2019 off the coast of Cape Cod, Massachusetts, a summer feeding grounds for many baleen whale species. Researchers took chemical measurements, recorded zooplankton and fish biomass, and whale locations over a series of transects across the ocean surface.

Their work revealed that, as hypothesized, zooplankton grazing on phytoplankton seems to result in higher localized concentrations of DMS compared to surrounding areas. In contrast, no association was found between fish biomass and DMS concentration. Simulations based on their measurements show that if large marine predators, such as whales, are able to detect the DMS concentration gradient, following increasing concentrations of DMS would allow them to reach denser zooplankton feeding areas than if they swam randomly.

"We plan to expand this research project in the future to investigate the relationship between DMS and predation by measuring the concentration of the chemical alongside marine predator movement trajectories," said Professor Kei Toda, who led the chemical measurements. "We also plan to explore other attractant chemicals and study their relationship with the behavior of marine predators like whales, seabirds and penguins. A pilot study tagging humpback whales to examine their movements in relation to DMS was conducted in Antarctica in February 2020, but there are still some issues that need to be addressed to pursue the relationship between chemical substances and predation. We believe that we will have some interesting findings in the near future."

Credit: 
Kumamoto University

Oncotarget: Targeting engineered cytokine with interleukin to the neovasculature of tumors

image: Activity of Neo&trade;-L19 in F9 teratocarcinoma or WEHI-164 fibrosarcoma tumor bearing mice. (A) F9 teratocarcinoma. Left: Tumor bearing mice received 3 injections (?) of Neo&trade;-L19, Neo&trade;-KSF or saline (PBS) when the tumors reached an average size of 90 mm3. The data is represented as the mean ± SD. Statistical analysis was performed by two-way ANOVA with post Bonferroni test (Not significant P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). All the immunocytokine treatments were statistically different from the saline treatment on day 14 (****P < 0.0001). On day 20, Neo&trade;-L19 10 &mu;g per inj (**P < 0.01) and Neo&trade;-L19 100 &mu;g per inj (****P < 0.0001) were different from the Neo&trade;-KSF (100 &mu;g per inj) group. Right: Body weight changes during the treatment represented as the mean ± SD. (B) WEHI-164 fibrosarcoma. Left: Tumor bearing mice received 2 equimolar injections (?) of Neo&trade;-L19, Neo&trade;-KSF, His6-Neo&trade; or saline (PBS) when the tumors reached an average size of 90 mm3. The data is represented as the mean ± SD. On day 16, the Neo&trade;-L19 (****P < 0.0001) and Neo&trade;-KSF (*P < 0.05) groups showed a significant difference to the saline group. On day 16, Neo&trade;-L19 was different from the His6-Neo&trade; (***P < 0.001) and Neo&trade;-KSF (*P < 0.05) groups. On day 17, Neo&trade;-L19 and Neo&trade;-KSF was not significantly different (P > 0.05). Right: Body weight changes during the treatment represented as the mean ± SD. Only significant differences between treatment groups have been indicated. ¥only two mice remaining in the group. CR: complete response.

Image: 
Correspondence to - Michael R. Mortensen - michael.mortensen@pharma.ethz.ch

Oncotarget recently published "Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors" by Mortensen, et al. which reported that there is a growing interest in the antibody-based delivery of cytokines to the tumor environment as a means to boost the anti-cancer activity of tumor-resident T cells and NK cells.

Here, the authors described the expression and characterization of fusion proteins, featuring the L19 antibody and an engineered cytokine with interleukin-2 and interleukin-15 properties.

The cytokine moiety was fused either at the N-terminal or at the C-terminal extremity and both fusion proteins showed a selective tumor accumulation in a quantitative biodistribution experiment.

The N-terminal fusion inhibited tumor growth in immunocompetent mice bearing F9 carcinomas or WEHI-164 sarcomas when used as a single agent.

These results indicate that the antibody-based delivery of engineered cytokines to the tumor neovasculature may mediate a potent anticancer activity.

Dr. Michael R. Mortensen from The Department of Chemistry and Applied Biosciences (D-CHAB) at The Institute for Pharmaceutical Sciences (IPW) in Zurich, Switzerland said, "Cancer immunotherapy relies on the activation of certain leukocytes (most typically, T cells and/or natural killer cells), with the aim to induce a selective biocidal activity against tumor cells."

IL2 muteins may alter the interaction of the cytokine with one or more of the IL2 receptor subunits, thus altering the selectivity towards the intermediate affinity receptor or towards the high-affinity receptor.

Since regulatory T cells predominantly express the high-affinity receptor, the selective activation of the intermediate affinity receptor has attracted considerable research efforts.

In a second approach, an increased selectivity towards the intermediate affinity IL2 receptor was achieved by blocking the interaction with CD25 either through IL2 mutations or by antibody blockade of the IL2 epitope involved in CD25 binding.

The Oncotarget authors described a series of engineered cytokines, which displayed biological features intermediate between those of IL2 and of IL15. IL15 interacts with CD122 and CD132 like IL2 but recognizes a different alpha subunit.

One of the new computationally designed cytokine variants, termed by the authors Neoleukin™-2/15, exhibited an increased affinity towards the receptor components shared by IL2 and IL15, with a complete absence of CD25 binding. Moreover, the newly engineered cytokine was much more stable compared to wild-type IL2.

The Mortensen Research Team concluded in their Oncotarget Research Paper that for certain cytokines the fusion with a tumor-homing antibody allows the creation of novel biopharmaceuticals, which display a preferential uptake in tumor lesions and which perform substantially better than the corresponding nontargeted cytokine in immunocompetent mouse models.

These authors and others have reported that not all cytokine payloads can be efficiently delivered to the tumor by fusion with antibodies.

Cytokine trapping at a low dose has been reported for fusion proteins based on interferon-gamma, but also for IL15 fusions.

Neo™-L19 is not glycosylated and the authors were pleased to see how the L19-based targeted delivery of the engineered IL2 and IL15 mimic led to an improved therapeutic effect for the F9 teratocarcinoma model. The contribution of L19-based targeting to an increased therapeutic index was less striking in the WEHI-164 model.

Collectively, the results presented indicate that a new fusion protein could be created, which displayed an excellent performance in biodistribution studies and which mediated a potent anticancer activity in two immunocompetent mouse models of cancer when used as a single agent.

The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may deserve to be investigated in clinical trials.

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27772

Full text - https://www.oncotarget.com/article/27772/text/

Correspondence to - Michael R. Mortensen - michael.mortensen@pharma.ethz.ch

Keywords - immunotherapy, immunocytokines, EDB of fibronectin, antibody-cytokine fusion proteins, engineered cytokine

About Oncotarget

Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105

Credit: 
Impact Journals LLC

Discovery of a mechanism by which epithelial tumours cause developmental delays

image: The ring gland is the equivalent to the human's prothoracic gland, responsible for steroidal hormone production.

Image: 
IRB Barcelona

The systemic balance that coordinates the growth of an organism and its progress through the different stages of development occurs across the animal world and is regulated by internal and external signals. Examples of this balance are puberty in humans and metamorphosis in flies. These are transitions characterised by the production of steroid hormones and they mark the turning point that will determine the halting of growth and entry into the adult state. Certain human diseases, such as cancer and inflammatory bowel diseases (IBDs), cause a delay in this transition.

Led by Dr. Marco Milán, scientists at IRB Barcelona have discovered the mechanism by which malignant epithelial tumours affect the production of steroid hormones. Specifically, these researchers have found that the Drosophila Upd3 protein (equivalent to human Interleukin-6) is the main signal produced by tumour cells to influence hormone production and activate signalling pathways that block the transition to adulthood.

"This finding is highly relevant and can help us understand delays in the transition to puberty caused by various medical conditions in adolescents. In the end, what happens is that a damaged organ sends signals to the body to warning that it is not prepared for a process of change," explains Dr. Milán, ICREA researcher and head of the Development and Growth Control laboratory at IRB Barcelona.

A model to study cancer

To carry out this study, Dr. Milán's group has used the genetic potential of the Drosophila fly to induce alterations in the epithelial tissue that simulate a tumour-like growth and mimic the capacity found in human carcinomas to send systemic signals.

"An animal model like the fly Drosophila allows us to study the entire phenomenon using a systemic approach. In this case, we have observed that tumour cells not only produce Upd3 to regulate the production of steroid hormones but also other molecules that act synergistically," says Daniela Romão, PhD student and first author of the article. "Interestingly, some of these signals cause a response from the body that resembles what happens in diabetic patients," says Daniela. These results open up new avenues to better understand why diabetes is a risk component in cancer patients.

Credit: 
Institute for Research in Biomedicine (IRB Barcelona)

Synthesis of a rare metal complex of nitrous oxide opens new vistas for

image: Two peas in a pod. Analogous metal complexes of nitrous oxide and carbon dioxide help to rationalize differences and similarities in the chemistry of two important greenhouse gases.

Image: 
Monika Stolar and Chris Gendy

Like its chemical relative carbon dioxide (CO2), nitrous oxide (N2O) is an important greenhouse gas and the dominant ozone-depleting substance emitted in the 21st Century. Consequently, strategies for limiting its emissions and its catalytic decomposition with metals are being developed. A recent study indicates that nitrous oxide can bind to metals similarly to carbon dioxide, which helps to design new complexes with even stronger bonding. This could allow the use of nitrous oxide in synthetic chemistry or help to degrade it to substances harmless to the atmosphere. The results were reported in the journal Angewandte Chemie International Edition as a Very Important Paper on February 17th 2021.

A comprehensive analysis of the global N2O budget has shown that its emissions have been increasing for the past four decades, with agricultural activities responsible for the growth. Even though N2O is present in the atmosphere at a concentration 1000 times less than CO2, it is approximately 300 times more potent as a greenhouse gas.

In nature, N2O is converted by enzymes into N2 and H2O. The process can be mimicked in a laboratory setting using catalytic metal complexes. Surprisingly, well-defined complexes of N2O with transition metals are exceedingly rare, even though CO2 has rich and well-documented coordination chemistry. The vastly dissimilar behaviour of these two related small molecules has been attributed to the poor ligand characteristics of N2O in comparison to CO2, but the origins and details of this justification are difficult to track.

"The more information we tried to find on the topic, the closer we headed to circular reasoning," says Dr. Heikki M. Tuononen from the University of Jyväskylä, Finland. "In many cases, some property of N2O was highlighted, but they are almost all characteristic to CO2 as well", he continues.

"This puzzle was one of the reasons why, during Dr. Tuononen's visit to Calgary as a Killam Scholar, our research teams decided to join forces and synthesize analogous metal complexes of N2O and CO2, and study the metal-ligand interaction in detail", tells Dr. Roland Roesler from the University of Calgary, Canada.

A rare metal complex of N2O stable even at room temperature

The results of the two-year investigation showed that, contrary to the general view, the metal binding ability of N2O is equally good or even better than that of CO2.

"It appears that the oxidizing character of N2O is mostly, if not entirely, responsible for the scarcity of metal complexes employing this ligand", says Dr. Tuononen.

"Once we had the right metal partner for N2O, their binding was strong enough that a rare side-on bound complex could be isolated and characterized even at room temperature", continues Dr. Chris Gendy, a former Ph.D. student at University of Calgary who was partially responsible of the synthetic work.

In addition to showing that N2O has better intrinsic ability to bind to metals than heretofore recognized, the work of the two research teams allows the rational design of N2O complexes that are even more stable than the ones characterized thus far. This could, in turn, open new avenues for using N2O in synthetic chemistry.

"N2O is in many ways a great oxidant. It is thermodynamically strong, relatively cheap, and gives N2 as the only side product", explains Dr. Tuononen.

"It would certainly be great to see more widespread use of N2O as an oxidant in metal-catalysed reactions. At the same time, we should not forget the role it plays in the atmosphere", adds Dr. Roesler.

"Nature has found elegant enzymatic pathways to convert N2O into products that are harmless to the atmosphere. We should aim for the same with our manmade emissions using novel catalysts", the research teams conclude.

Credit: 
University of Jyväskylä - Jyväskylän yliopisto

Researchers discover potential new therapeutic targets on SARS-CoV-2 Spike protein

UNIVERSITY PARK, Pa. -- The COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the infection process, as this knowledge is useful in designing vaccines and therapeutics. Now, a team of scientists has discovered additional locations on the Spike protein that may not only help to explain how certain mutations make emerging variants more infectious but also could be used as additional targets for therapeutic intervention.

"Significant research is underway to examine how the receptor binding domain (RBD) at the tip of the club-shaped SARS-CoV-2 Spike protein attaches to an ACE2 receptor on a human cell, but little is known about the other changes that occur in the Spike protein as a result of this attachment," said Ganesh Anand, associate professor of chemistry, Penn State. "We have uncovered 'hotspots' further down on the Spike protein that are critical for SARS-CoV-2 infection and may be novel targets beyond the RBD for therapeutic intervention."

Anand and his colleagues used a process, called amide hydrogen-deuterium exchange mass spectrometry (HDXMS), to visualize what happens when the SARS-CoV-2 Spike protein binds to an ACE2 receptor. HDXMS uses heavy water or deuterium oxide (D2O), a naturally occurring, non-radioactive isotope of water formed from heavy hydrogen or deuterium, as a probe for mapping proteins. In this case, the team placed SARS-CoV-2 Spike protein and ACE2 receptors in heavy water and obtained footprints of ACE2 on the Spike protein.

"If you put the Spike protein and ACE2 receptor into a solution that's made with D2O, the surfaces and more floppy regions on both proteins will more readily exchange hydrogens for deuterium, compared to their interiors," said Anand. "And footprints of each protein on the binding partner can be readily identified from areas where you see little deuterium and only detect normal hydrogen."

Using this technique, the team determined that binding of the Spike protein and ACE2 receptor is necessary for furin-like proteases -- a family of human enzymes -- that act to snip off the tip, called the S1 subunit, of the Spike protein, which is the next step in the virus's infection of the cell. The findings published on Feb. 8 in the journal eLife.

"The Spike proteins on the surface of the virus swivel to search and latch onto the ACE2 receptor," said Anand. "ACE2 can be likened to a hand holding strands of hair -- the Spike protein clusters. Binding to Spike stabilizes it so it can be cut by furin protease scissors. After furin proteases clip the protein, the part that remains -- the S2 subunit -- is what fuses with the cell's membranes, allowing entry into the cell."

Anand noted that researchers have already learned much about how the Spike protein and ACE2 receptor bind together, but until now no one knew how this binding relayed the message to the furins to cut the protein. He explained that the phenomenon is called allostery, meaning "action at a distance."

"Our findings show ACE2 receptor binding to SARS-CoV-2 Spike protein causes long-range changes and allosterically enhances protease cutting at the distal S1/S2 cleavage site," he said.

Anand said that researchers are currently focusing only on therapeutics that block the Spike protein from binding to the ACE2 receptor.

"In this paper, we're suggesting that's not the only vulnerability that can be targeted," he said. "Maybe the S1/S2 cleavage that is necessary for furin cleavage can serve as a new target for inhibitory therapeutics against the virus. This study also may help in explaining how mutations in emerging variants might alter dynamics and allostery of ACE2 binding, potentially increasing infectiousness of the SARS-CoV-2 virus."

Credit: 
Penn State

CHOP experts describe types of rashes associated with MIS-C

image: Annular plaques on the back of a patient with MIS-C

Image: 
Children's Hospital of Philadelphia

Philadelphia, February 22, 2021--In April 2020, pediatricians began recognizing a puzzling syndrome in children involving hyperinflammation that results in an array of symptoms, including fever, gastrointestinal distress and rash. The syndrome, thought to be a post-infectious complication of SARS-CoV-2 infection, was given the name Multisystem Inflammatory Syndrome Children, or MIS-C. However, diagnosing the condition has posed challenges, as many of its symptoms, including rash, are common in many other pediatric infections.

In a study published in Open Forum Infectious Diseases, researchers at Children's Hospital of Philadelphia (CHOP) describe the array of rashes seen in MIS-C patients at their hospital through late July 2020, providing photos and information that could help doctors diagnose future cases.

"We hope the information provided in this research letter will help general pediatricians and emergency department physicians who may wonder if a patient with a fever requires a more extensive examination," said Audrey Odom John, MD, PhD, Chief of the Division of Pediatric Infectious Diseases at CHOP and senior author of the paper. "Given that some rashes associated with MIS-C are distinctive, we also imagine these images could help many parents who are looking for signs that their child needs prompt evaluation."

The research team analyzed the MIS-C-associated rashes of seven patients seen at CHOP. Although the researchers did not observe a single, defining rash associated with COVID-19, there were several types of rashes that were common in these patients, both in appearance and location.

In terms of rash location, all patients in the study developed a rash on their lower body, and five of the seven patients had a rash on their inner thighs. Rashes on the chest and upper extremities were also common, occurring in four out of seven patients.

More than half of the patients presented with small-to-medium annular plaques, which look like dime-size circles, on their chest and back. More than half of the patients in the study also developed purpura, tiny red spots, often in the center of the dime-like annular plaques.

While some patients did develop a cherry-red rash on the bottoms of their feet and palms of their hands, this sort of rash was seen in less than half of the patients in the study. Rashes on the face were uncommon, and the rashes rarely itched.

"Depending on the age of the child, parents may not regularly look at the child's chest, back or thighs, but this is where the rashes associated with MIS-C tend to appear," said John. "Given that MIS-C is still largely a diagnosis of exclusion, parents and health care providers should look for rashes in these locations if the child has a fever that seems suspicious."

Credit: 
Children's Hospital of Philadelphia